A phase II trial evaluating irinotecan with 5-fluorouracil plus leucovorin [folinic acid] in patients with relapsed/refractory upper gastrointestinal tumours.

Trial Profile

A phase II trial evaluating irinotecan with 5-fluorouracil plus leucovorin [folinic acid] in patients with relapsed/refractory upper gastrointestinal tumours.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2012

At a glance

  • Drugs Fluorouracil; Folinic acid; Irinotecan
  • Indications Gastric cancer; Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top